M, M., L, J., T, M., JP, F., F, T., JS, C., . . . L, Z. (2024). Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review. Journal of the American Medical Directors Association, 25(3), 439. https://doi.org/10.1016/j.jamda.2023.11.025
Chicago Style (17th ed.) CitationM, Mellot, Jawal L, Morel T, Fournier JP, Tubach F, Cadwallader JS, Christiaens A, and Zerah L. "Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review." Journal of the American Medical Directors Association 25, no. 3 (2024): 439. https://doi.org/10.1016/j.jamda.2023.11.025.
MLA (9th ed.) CitationM, Mellot, et al. "Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review." Journal of the American Medical Directors Association, vol. 25, no. 3, 2024, p. 439, https://doi.org/10.1016/j.jamda.2023.11.025.